Approximately 40 lawsuits filed over problems associated with the Mirena intrauterine contraceptive device have been coordinated in multidistrict litigation before a federal judge in New York.
The suits allege that the device, which a doctor implants into a woman during an office visit, can migrate from its original position, tearing the uterine wall and requiring surgery to remove it. Plaintiffs’ lawyers have said in court documents that they expect hundreds, possibly thousands of cases against Bayer Healthcare Pharmaceuticals Inc.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
